MA48956A - Composés mic-1 et utilisations associées - Google Patents
Composés mic-1 et utilisations associéesInfo
- Publication number
- MA48956A MA48956A MA048956A MA48956A MA48956A MA 48956 A MA48956 A MA 48956A MA 048956 A MA048956 A MA 048956A MA 48956 A MA48956 A MA 48956A MA 48956 A MA48956 A MA 48956A
- Authority
- MA
- Morocco
- Prior art keywords
- mic
- compounds
- associated uses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factors [FGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2017085576 | 2017-05-23 | ||
CN2017113335 | 2017-11-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA48956A true MA48956A (fr) | 2020-04-08 |
Family
ID=62567604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA048956A MA48956A (fr) | 2017-05-23 | 2018-05-23 | Composés mic-1 et utilisations associées |
Country Status (17)
Country | Link |
---|---|
US (3) | US10398782B2 (fr) |
EP (1) | EP3630805A1 (fr) |
JP (1) | JP7015322B2 (fr) |
KR (1) | KR20200010353A (fr) |
CN (1) | CN111183148A (fr) |
AU (1) | AU2018272911B2 (fr) |
BR (1) | BR112019024102A2 (fr) |
CA (1) | CA3064320A1 (fr) |
CL (1) | CL2019003441A1 (fr) |
CO (1) | CO2019013768A2 (fr) |
MA (1) | MA48956A (fr) |
MX (1) | MX2019013801A (fr) |
PE (1) | PE20200514A1 (fr) |
PH (1) | PH12019550241A1 (fr) |
RU (1) | RU2019141031A (fr) |
TW (1) | TWI710377B (fr) |
WO (1) | WO2018215525A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10588980B2 (en) | 2014-06-23 | 2020-03-17 | Novartis Ag | Fatty acids and their use in conjugation to biomolecules |
US20190248852A1 (en) * | 2016-05-24 | 2019-08-15 | Novo Nordisk A/S | MIC-1 Compounds and Use Thereof |
TWI710377B (zh) * | 2017-05-23 | 2020-11-21 | 丹麥商諾佛 儂迪克股份有限公司 | Mic-1化合物及其用途 |
EP4041281A1 (fr) | 2019-10-04 | 2022-08-17 | Amgen Inc. | Utilisation de gdf15 pour le traitement d'un syndrome cardiométabolique et d'autres affections |
CN116925237A (zh) | 2019-12-31 | 2023-10-24 | 北京质肽生物医药科技有限公司 | Glp-1和gdf15的融合蛋白以及其缀合物 |
CN115925994B (zh) | 2020-09-30 | 2023-09-22 | 北京质肽生物医药科技有限公司 | 多肽缀合物和使用方法 |
WO2023154953A1 (fr) | 2022-02-14 | 2023-08-17 | Ngm Biopharmaceuticals, Inc. | Polypeptides gdf15 pour le traitement et la prévention de maladies auto-immunes |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1276849A4 (fr) | 2000-04-12 | 2004-06-09 | Human Genome Sciences Inc | Proteines fusionnees a de l'albumine |
CN1241946C (zh) | 2002-07-01 | 2006-02-15 | 美国福源集团 | 对多种细胞具刺激增生作用的人血清白蛋白重组融合蛋白 |
EP2774620A1 (fr) | 2004-04-13 | 2014-09-10 | St Vincent's Hospital Sydney Limited | Procédé de modulation de perte de poids |
US20050256576A1 (en) | 2004-05-13 | 2005-11-17 | Moskowitz Nathan C | Artificial expansile total lumbar and thoracic discs for posterior placement without supplemental instrumentation and its adaptation for anterior placement of artificial cervical, thoracic and lumbar discs |
DK1751184T3 (da) | 2004-05-13 | 2009-11-23 | Lilly Co Eli | FGF-21 fusionsproteiner |
WO2006010891A2 (fr) | 2004-07-26 | 2006-02-02 | Asterion Limited | Lieurs |
ES2531372T3 (es) | 2006-10-13 | 2015-03-13 | Novo Nordisk Healthcare Ag | Enzimas de procesamiento fusionadas a marcadores de proteínas básicas |
KR20100058541A (ko) | 2007-08-15 | 2010-06-03 | 아뮤닉스 인코포레이티드 | 생물학적 활성 폴리펩티드의 특성을 변경하기 위한 조성물 및 방법 |
US20100317057A1 (en) | 2007-12-28 | 2010-12-16 | Novo Nordisk A/S | Semi-recombinant preparation of glp-1 analogues |
EP2340049B1 (fr) | 2008-09-12 | 2015-11-11 | Novo Nordisk A/S | Procédé d'acylation d'un peptide ou d'une protéine |
ES2692495T3 (es) * | 2009-01-23 | 2018-12-03 | Novo Nordisk A/S | Derivados del FGF21 con aglutinante de albúmina A-B-C-D-E- y sus usos |
CN116925238A (zh) * | 2009-02-03 | 2023-10-24 | 阿穆尼克斯制药公司 | 延伸重组多肽和包含该延伸重组多肽的组合物 |
US8680050B2 (en) | 2009-02-03 | 2014-03-25 | Amunix Operating Inc. | Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same |
CN103533951B (zh) | 2011-04-08 | 2017-04-19 | 安姆根有限公司 | 使用生长分化因子15(gdf‑15)治疗或改善代谢障碍的方法 |
US9714276B2 (en) | 2012-01-26 | 2017-07-25 | Amgen Inc. | Growth differentiation factor 15 (GDF-15) polypeptides |
WO2013148117A1 (fr) * | 2012-03-27 | 2013-10-03 | Ngm Biopharmaceuticals, Inc. | Compositions et méthodes d'utilisation pour le traitement de troubles métaboliques |
EP2950807B1 (fr) | 2013-01-30 | 2018-03-28 | NGM Biopharmaceuticals, Inc. | Compositions et procédés à utiliser pour le traitement de troubles métaboliques |
US9161966B2 (en) | 2013-01-30 | 2015-10-20 | Ngm Biopharmaceuticals, Inc. | GDF15 mutein polypeptides |
EA202092386A1 (ru) | 2013-07-31 | 2021-04-30 | Эмджен Инк. | Конструкции на основе фактора дифференцировки и роста 15 (gdf15) |
CN116655801A (zh) | 2013-08-22 | 2023-08-29 | 阿塞勒隆制药公司 | TGF-β受体II型变体及其用途 |
US10588980B2 (en) | 2014-06-23 | 2020-03-17 | Novartis Ag | Fatty acids and their use in conjugation to biomolecules |
US9272019B2 (en) * | 2014-06-24 | 2016-03-01 | Novo Nordisk A/S | MIC-1 fusion proteins and uses thereof |
RS59154B1 (sr) | 2014-12-23 | 2019-10-31 | Novo Nordisk As | Fgf21 derivati i njihova upotreba |
MA41794A (fr) * | 2015-03-18 | 2018-01-23 | The California Institute For Biomedical Res | Agents thérapeutiques modifiés et compositions associées |
CA3000290C (fr) | 2015-10-02 | 2023-02-21 | Julius-Maximilians-Universitat Wurzburg | Gdf-15 utilise comme marqueur diagnostique pour prevoir le resultat clinique d'un traitement avec des bloqueurs de point de controle immunitaire |
GB201517528D0 (en) | 2015-10-02 | 2015-11-18 | Julius Maximillians Universitãt Würzburg | GDF-15 as a diagnosis marker for melanoma |
IL299478A (en) | 2015-10-02 | 2023-02-01 | Univ Wuerzburg J Maximilians | Combined treatment using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint inhibitors |
US20190000923A1 (en) * | 2015-12-22 | 2019-01-03 | Novartis Ag | Methods of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15) |
US20190248852A1 (en) * | 2016-05-24 | 2019-08-15 | Novo Nordisk A/S | MIC-1 Compounds and Use Thereof |
TWI710377B (zh) | 2017-05-23 | 2020-11-21 | 丹麥商諾佛 儂迪克股份有限公司 | Mic-1化合物及其用途 |
-
2018
- 2018-05-21 TW TW107117256A patent/TWI710377B/zh active
- 2018-05-23 AU AU2018272911A patent/AU2018272911B2/en not_active Ceased
- 2018-05-23 CN CN201880035246.9A patent/CN111183148A/zh not_active Withdrawn
- 2018-05-23 US US15/986,961 patent/US10398782B2/en active Active
- 2018-05-23 JP JP2019563484A patent/JP7015322B2/ja active Active
- 2018-05-23 WO PCT/EP2018/063476 patent/WO2018215525A1/fr active Application Filing
- 2018-05-23 US US16/614,454 patent/US20200079829A1/en not_active Abandoned
- 2018-05-23 RU RU2019141031A patent/RU2019141031A/ru unknown
- 2018-05-23 KR KR1020197037299A patent/KR20200010353A/ko not_active Application Discontinuation
- 2018-05-23 EP EP18730247.6A patent/EP3630805A1/fr active Pending
- 2018-05-23 PE PE2019002429A patent/PE20200514A1/es unknown
- 2018-05-23 CA CA3064320A patent/CA3064320A1/fr not_active Withdrawn
- 2018-05-23 BR BR112019024102-7A patent/BR112019024102A2/pt not_active Application Discontinuation
- 2018-05-23 MX MX2019013801A patent/MX2019013801A/es unknown
- 2018-05-23 MA MA048956A patent/MA48956A/fr unknown
-
2019
- 2019-11-15 PH PH12019550241A patent/PH12019550241A1/en unknown
- 2019-11-25 CL CL2019003441A patent/CL2019003441A1/es unknown
- 2019-12-06 CO CONC2019/0013768A patent/CO2019013768A2/es unknown
-
2022
- 2022-12-19 US US18/083,729 patent/US20230364248A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US10398782B2 (en) | 2019-09-03 |
CN111183148A (zh) | 2020-05-19 |
WO2018215525A1 (fr) | 2018-11-29 |
TWI710377B (zh) | 2020-11-21 |
MX2019013801A (es) | 2020-01-30 |
JP2020520918A (ja) | 2020-07-16 |
WO2018215525A8 (fr) | 2020-01-02 |
US20200079829A1 (en) | 2020-03-12 |
BR112019024102A2 (pt) | 2020-06-02 |
AU2018272911B2 (en) | 2022-09-08 |
TW201900219A (zh) | 2019-01-01 |
CL2019003441A1 (es) | 2020-05-08 |
CO2019013768A2 (es) | 2020-04-01 |
US20180339057A1 (en) | 2018-11-29 |
PH12019550241A1 (en) | 2020-12-07 |
JP7015322B2 (ja) | 2022-02-02 |
AU2018272911A1 (en) | 2019-12-19 |
US20230364248A1 (en) | 2023-11-16 |
KR20200010353A (ko) | 2020-01-30 |
RU2019141031A (ru) | 2021-06-16 |
RU2019141031A3 (fr) | 2021-07-16 |
EP3630805A1 (fr) | 2020-04-08 |
PE20200514A1 (es) | 2020-03-05 |
CA3064320A1 (fr) | 2018-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA50256A (fr) | Composés de pyrazolopyrimidinone et leurs utilisations | |
MA50618A (fr) | Polyrhérapies et leurs utilisations | |
MA41598A (fr) | Composés thérapeutiques de pyridazine et leurs utilisations | |
MA48956A (fr) | Composés mic-1 et utilisations associées | |
MA43205A (fr) | Composés pyy sélectifs et leurs utilisations | |
MA50173A (fr) | Composés activateurs de bisamide sarcomère et leurs utilisations | |
MA45857A (fr) | Composés et compositions, et utilisations associées | |
MA45113A (fr) | Composés mic-1 et leur utilisation | |
MA41495A (fr) | Composés benzoxaborole et leurs utilisations | |
DK3387930T3 (da) | Stofanordning | |
MA43141A (fr) | Nouveaux composés et leurs utilisations | |
MA46589A (fr) | Composés et utilisations de ces derniers | |
MA44020A (fr) | Composés antitumoraux | |
MA52365A (fr) | Composés et leurs utilisations | |
MA49621A (fr) | Composés bifonctionnels | |
MA45795A (fr) | Composés et compositions, et utilisations associées | |
MA52977A (fr) | Composés de cyanotriazole et leurs utilisations | |
MA52092A (fr) | Composés et leurs utilisations | |
MA51221A (fr) | Composés de pyrazolopyridinone | |
DE112018006116A5 (de) | Reibteil | |
MA49885A (fr) | Composés macrocycliques | |
MA44484A (fr) | Biomarqueurs de protéinopathies et utilisations associées | |
MA48946A (fr) | Composés | |
DK3453985T3 (da) | Bioklimatisk bygning | |
ES1225492Y (es) | Arnés dinámico |